develop
vaccin
essenti
prevent
futur
recurr
sever
acut
respiratori
syndrom
sar
caus
sar
coronaviru
sarscov
spike
protein
especi
receptorbind
domain
rbd
sarscov
play
import
role
prevent
sar
infect
thu
import
compon
sar
vaccin
develop
studi
express
residu
rbd
protein
chines
hamster
ovari
cho
cell
test
immun
respons
protect
immun
mous
model
result
show
recombin
protein
correctli
fold
abl
maintain
intact
conform
authent
antigen
could
induc
strong
humor
cellular
immun
respons
high
titer
neutral
antibodi
vaccin
mice
protein
elicit
potent
protect
immun
protect
vaccin
mice
sarscov
challeng
result
suggest
recombin
protein
great
potenti
develop
effect
safe
sar
subunit
vaccin
newli
emerg
infecti
diseas
sever
acut
respiratori
syndrom
sar
caus
sar
coronaviru
sarscov
zoonot
viru
like
origin
natur
reservoir
bat
intermedi
transmiss
via
palm
civet
raccoon
dog
final
transmit
human
transmiss
sarscov
human
human
led
global
outbreak
sar
though
sar
current
control
necessari
develop
effect
safe
vaccin
prevent
futur
sar
outbreak
may
aris
anim
reservoir
accident
due
laboratori
viru
escap
recent
develop
sar
vaccin
variou
categori
includ
inactiv
viru
vaccin
subunit
vaccin
dna
vaccin
viruslik
particl
viral
vectorbas
vaccin
differ
vaccin
combin
varieti
sar
vaccin
test
anim
includ
monkey
ferret
mice
hamster
evalu
human
vaccin
may
target
differ
antigen
viru
base
spike
protein
report
adenovirusbas
vaccin
express
protein
prevent
pneumonia
ferret
sarscov
challeng
stimul
potent
immun
respons
macaqu
recombin
sar
sprotein
elicit
neutral
antibodi
protect
mice
specif
humor
cellular
immun
respons
andor
protect
could
induc
sar
dna
vaccin
via
differ
vaccin
rout
sarscovlik
particl
carri
protein
protect
mice
viru
challeng
report
suggest
protein
play
import
role
prevent
sar
infect
previou
studi
demonstr
recombin
fusion
protein
consist
residu
receptorbind
domain
rbd
sarscov
protein
tag
fc
fragment
human
igg
could
induc
highli
potent
neutral
antibodi
respons
protect
immun
howev
one
potenti
disadvantag
vaccin
candid
fc
tag
ad
cterminu
hope
increas
immunogen
bind
fctag
immunogen
fc
receptor
antigenpres
cell
may
caus
advers
effect
use
vaccin
compon
human
express
recombin
rbd
residu
without
fuse
fc
chines
hamster
ovari
cho
cell
induc
rbdspecif
immun
respons
neutral
antibodi
could
fulli
protect
vaccin
mice
sarscov
challeng
viru
replic
detect
two
five
vaccin
mice
present
studi
express
rbd
protein
cover
residu
cell
like
newli
design
rbd
without
fc
tag
also
induc
strong
humor
cellular
immun
respons
high
titer
neutral
antibodi
induc
potent
protect
immun
protect
vaccin
mice
sarscov
challeng
result
suggest
great
potenti
develop
effect
safe
sar
subunit
vaccin
gene
construct
protein
express
purif
gene
construct
express
protein
done
previous
describ
gene
encod
fragment
contain
aa
sarscov
protein
rbd
region
plu
tag
c
terminu
amplifi
pcr
use
fulllength
plasmid
strain
templat
insert
gs
gene
express
vector
construct
recombin
plasmid
confirm
sequenc
analysi
briefli
recombin
plasmid
transient
transfect
use
fugen
transfect
reagent
roch
appli
scienc
indianapoli
cell
precultur
medium
american
type
cultur
collect
manassa
va
cultur
medium
replac
fresh
optimem
reducedserum
medium
invitrogen
carlsbad
ca
h
later
supernat
collect
h
posttransfect
cultur
supernat
contain
express
protein
ad
proteas
inhibitor
cocktail
roch
appli
scienc
purifi
use
column
promega
madison
wi
protein
yield
use
transient
transfect
method
mgl
supernat
reactiv
purifi
protein
determin
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
follow
western
blot
accord
previous
describ
protocol
briefli
purifi
protein
mgwell
separ
nonreduc
sdspage
boil
reduc
agent
gel
transfer
nitrocellulos
membran
biorad
laboratori
hercul
ca
block
overnight
block
buffer
contain
nonfat
milk
dissolv
tween
pbst
blot
incub
h
room
temperatur
serial
rbdspecif
monoclon
antibodi
mab
gener
laboratori
final
concentr
mgml
wash
three
time
blot
incub
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
zyme
carlsbad
ca
h
room
temperatur
signal
visual
ecl
western
blot
substrat
reagent
amersham
hyperfilm
ge
healthcar
piscataway
nj
group
five
femal
balbc
mice
wk
age
subcutan
vaccin
purifi
protein
mgmous
presenc
freund
complet
adjuv
fca
sigma
st
loui
mo
boost
twice
immunogen
mgmous
contain
freund
incomplet
adjuv
fia
sigma
interv
mice
inject
amount
pb
use
neg
control
sera
collect
preimmun
vaccin
analyz
igg
neutral
antibodi
respons
spleen
cell
collect
last
vaccin
use
detect
cellular
respons
parallel
experi
mice
challeng
sarscov
day
last
vaccin
analyz
viral
load
rna
copi
challeng
lung
tissu
postchalleng
vaccin
protocol
describ
detail
fig
mous
sera
analyz
use
elisa
igg
antibodi
specif
rbd
sarscov
protein
use
previous
describ
protocol
modif
briefli
plate
precoat
mlwell
protein
mgml
sat
overnight
block
nonfat
milk
h
serial
dilut
mous
sera
ad
plate
mlwell
incub
h
follow
three
wash
pbst
bound
antibodi
react
hrpconjug
goat
antimous
igg
du
et
al
three
wash
follow
ad
n
h
stop
reaction
absorb
nm
measur
elisa
plate
reader
tecan
system
san
jose
ca
neutral
assay
sarscov
pseudoviru
infect
done
accord
previous
establish
method
pseudotyp
viru
bear
sarscov
protein
defect
genom
express
luciferas
report
prepar
briefli
cell
cotransfect
plasmid
encod
codonoptim
sarscov
protein
plasmid
encod
envdefect
luciferaseexpress
genom
use
fugen
transfect
reagent
roch
appli
scienc
supernat
contain
sar
pseudoviru
harvest
h
posttransfect
use
singlecycl
infect
cell
express
cell
plate
cellswel
tissu
cultur
plate
h
preinfect
pseudoviruscontain
supernat
preincub
serial
dilut
mous
sera
h
ad
cell
h
cell
refe
fresh
medium
follow
lyse
cell
h
later
use
cell
lysi
buffer
promega
lysat
transfer
luminomet
plate
luciferas
substrat
promega
ad
plate
rel
luciferas
activ
determin
ultra
luminomet
tecan
system
neutral
sar
pseudoviru
calcul
present
neutral
antibodi
titer
nt
neutral
assay
live
sarscov
strain
genbank
access
done
previous
describ
neutral
antibodi
titer
sera
mice
immun
protein
detect
vero
cell
briefli
cell
seed
well
tissu
cultur
plate
h
infect
serial
twofold
dilut
serum
sampl
separ
mix
tissuecultur
infecti
dose
tcid
sarscov
strain
incub
h
ad
cell
triplic
cytopath
effect
cpe
observ
daili
record
day
postinfect
neutral
titer
determin
highest
dilut
sera
could
complet
prevent
cpe
least
well
nt
elispot
assay
done
use
mous
kit
mabtech
inc
mariemont
oh
accord
manufactur
protocol
previous
describ
method
briefli
elispot
plate
coat
antiifng
mab
overnight
block
contain
fb
h
room
temperatur
singlecel
suspens
cellswel
isol
vaccin
mous
spleen
ad
well
follow
incub
h
presenc
restrict
sarscov
rbdspecif
cytotox
lymphocyt
ctl
peptid
kcygvsatkl
th
peptid
nynykyrylr
final
concentr
mgml
plate
wash
pb
follow
incub
biotinyl
label
antimous
ifng
mab
h
room
temperatur
addit
wash
well
incub
streptavidinconjug
hrp
h
room
temperatur
develop
tmb
substrat
spot
cytokineproduc
cell
count
use
elispot
reader
immunospot
softwar
cellular
technolog
ltd
cleveland
oh
result
express
number
spotform
cell
per
input
cell
vaccin
mice
intranas
inocul
sarscov
strain
tcid
previous
describ
mice
sacrif
viru
challeng
lung
remov
store
virolog
detect
quantit
revers
transcriptas
polymeras
chain
reaction
qrtpcr
viral
rna
copi
lung
tissu
determin
qrtpcr
accord
previous
describ
protocol
briefli
total
rna
extract
mg
lung
tissu
use
rneasi
viru
replic
detect
titrat
inocul
viru
lung
tissu
collect
sacrif
mice
accord
previous
describ
protocol
briefli
lung
tissu
homogen
final
concentr
wv
suspens
dmem
tissu
homogen
centrifug
filter
inocul
monolay
vero
cell
seed
tissuecultur
plate
result
evalu
cultur
phasecontrast
microscopi
viral
titer
use
cpebas
tcid
test
calcul
reedmuench
method
viral
titer
express
log
tcid
g
tissu
lowest
detect
limit
log
tcid
g
total
amount
viru
calcul
multipli
weight
lung
tissu
viral
titer
measur
tissu
homogen
express
protein
correctli
fold
maintain
intact
conform
recogn
major
conform
epitopespecif
mab
rbd
express
rbd
protein
analyz
conform
use
mab
target
conform
epitop
rbd
shown
fig
express
protein
react
sarscov
rbd
induc
potent
respons
protect
select
mab
recogn
conform
epitop
strongest
reaction
conform
v
mab
also
react
mab
recogn
linear
epitop
rbd
result
demonstr
express
protein
correctli
fold
maintain
intact
conform
order
detect
humor
immun
respons
induc
protein
sera
collect
vaccin
mice
analyz
elisa
rbdspecif
antibodi
shown
fig
sera
first
second
third
vaccin
show
strong
antibodi
respons
last
vaccin
demonstr
highest
reactiv
sera
preimmun
pre
pb
control
background
level
antibodi
respons
determin
titer
rbdspecif
antibodi
induc
protein
sera
collect
last
vaccin
titrat
seri
fourfold
dilut
measur
fig
indic
elicit
high
level
rbdspecif
antibodi
endpoint
titer
contrast
background
level
antibodi
detect
pb
control
group
fig
sera
collect
last
vaccin
test
neutral
activ
infect
sar
pseudoviru
cell
live
sarscov
vero
cell
shown
fig
ae
nt
reach
mous
sera
neutral
sar
pseudoviru
infect
level
higher
pb
control
high
titer
rbdspecif
igg
antibodi
also
confirm
neutral
live
sarscov
infect
vero
cell
ae
nt
neutral
antibodi
maintain
vaccin
mice
fig
result
suggest
highli
potent
neutral
antibodi
may
induc
protein
sar
pseudoviru
live
sarscov
infect
cell
cultur
vitro
detect
cellular
immun
respons
potenti
induc
protein
mous
splenocyt
collect
last
vaccin
tcell
respons
detect
elispot
splenocyt
stimul
peptid
specif
ctl
cell
th
cell
respect
rbd
sarscov
detect
cellular
immun
respons
purifi
rbd
protein
also
use
stimul
final
concentr
mgml
shown
tabl
induc
rbdspecif
ctl
respons
particularli
high
frequenc
ctl
cell
stimul
ctl
peptid
evalu
thcell
respons
upon
stimul
peptid
indic
protein
may
elicit
rel
higher
level
respons
repres
product
high
number
cell
addit
induct
respons
indic
presenc
cell
spleen
vaccin
mice
result
tabl
also
show
cellular
immun
respons
induc
protein
stimul
gener
higher
elicit
ctl
peptid
th
peptid
stimul
alon
probabl
recombin
protein
cover
rbd
region
contain
much
ctl
andor
th
epitop
contrast
background
level
cellular
respons
detect
splenocyt
mice
pb
control
tabl
cell
stimul
supernat
cho
cultur
data
shown
data
suggest
express
protein
abl
induc
rel
high
level
cellular
immun
respons
vaccin
mice
contrast
high
level
viru
replic
found
lung
tissu
pb
control
mice
fig
result
confirm
protein
abl
complet
protect
vaccin
mice
subsequ
sarscov
challeng
investig
relationship
neutral
antibodi
viru
protect
compar
serum
neutral
antibodi
titer
viral
rna
copi
lung
tissu
mice
challeng
live
sarscov
shown
fig
detect
viru
replic
accompani
high
titer
neutral
antibodi
pseudoviru
vitro
detect
rrbdvaccin
mice
rabbit
protect
humor
respons
detect
proteinvaccin
rabbit
antisera
contain
neutral
antibodi
sarscov
infect
vivo
report
demonstr
proteininduc
neutral
antibodi
play
import
role
fight
sarscov
infect
previous
report
recombin
protein
contain
rbd
fc
tag
induc
highli
potent
neutral
antibodi
respons
protect
immun
vaccin
anim
order
elimin
potenti
advers
effect
might
induc
use
vaccin
compon
human
express
sever
rbd
protein
fc
tag
remov
mammalian
cell
insect
cell
e
coli
rbdec
unlik
rbd
protein
express
e
coli
may
induc
complet
protect
live
sarscov
challeng
vaccin
mice
rbd
protein
express
cell
protect
major
mice
viru
challeng
viru
replic
detect
two
five
mice
express
rbd
protein
cell
line
newlydesign
protein
elicit
high
titer
rbdspecif
antibodi
potent
neutral
activ
sar
pseudoviru
live
sarscov
infect
cell
cultur
vitro
like
rrbd
protein
express
e
coli
cell
abl
protect
vaccin
mice
sarscov
challeng
vivo
fig
similarli
rrbd
protein
express
mammalian
cell
rbd
protein
without
fc
fusion
tag
react
major
mab
specif
conform
linear
epitop
rbd
suggest
maintain
intact
conform
proper
antigen
fig
similarli
protein
stabl
cell
line
could
establish
cell
line
longterm
express
protein
data
shown
protein
residu
express
extens
residu
c
terminu
protein
residu
extend
fragment
may
assist
rbd
refold
stabl
immunogen
conform
induc
potent
protect
immun
vaccin
anim
futur
comparison
structur
immun
respons
longterm
protect
two
protein
warrant
addit
humor
immun
respons
cellular
immun
respons
may
play
role
clearanc
sarscov
infect
cell
involv
immun
respons
viru
infect
memori
tcell
respons
protein
shown
continu
sarscov
infect
indic
product
ifng
increas
specif
cytokineproduc
cell
detect
elispot
stimul
peptid
contain
sarscov
rbdspecif
tcell
tcell
epitop
respect
protein
pb
use
control
data
express
mean
ae
se
cytokin
spotform
cell
sfc
cell
five
mice
per
group
fig
detect
protect
immun
mice
immun
protein
pb
control
mice
vaccin
protein
challeng
live
sarscov
sarscov
replic
lung
tissu
challeng
mice
detect
express
log
tcid
g
tissu
detect
limit
log
tcid
g
lung
tissu
indic
five
mice
use
per
group
b
number
sarscov
rna
copi
lung
tissu
mice
challeng
live
sarscov
measur
qrtpcr
express
rna
copiesmg
lung
tissu
neutral
antibodi
titer
nt
sera
mice
also
shown
data
present
mean
ae
se
five
mice
per
group
experi
perform
three
time
similar
result
obtain
du
et
al
ctl
respons
induc
fragment
encod
residu
immun
mice
dna
fragment
encod
protein
demonstr
induc
tcell
respons
phase
human
studi
proteinexpress
dna
vaccin
elicit
sarscovspecif
tcell
respons
test
healthi
adult
tcell
respons
individu
ctl
respons
detect
studi
mous
splenocyt
evid
high
immunogen
antigen
express
rbd
protein
use
vaccin
candid
tabl
although
humor
cellular
immun
respons
import
suppress
sarscov
infect
neutral
antibodi
may
key
factor
protect
mice
subsequ
viru
challeng
longterm
protect
mediat
neutral
antibodi
could
achiev
immun
mice
singl
dose
attenu
vesicular
stomat
viru
vsv
recombin
bear
protein
vsv
recombin
secret
protein
contain
residu
protein
could
provid
suffici
neutral
antibodi
protect
sarscov
infect
protect
immun
seen
mice
vaccin
proteinexpress
dna
vaccin
mediat
humor
immun
rather
tcelldepend
immun
mechan
agreement
report
result
show
neutral
antibodi
induc
protein
play
signific
role
suppress
sarscov
infect
fig
other
demonstr
rbd
sarscov
protein
basi
develop
vaccin
sarscov
high
titer
neutral
antibodi
protect
immun
could
induc
subunit
vaccin
base
rbd
protein
without
fusion
segment
howev
rbdbase
vaccin
without
fusion
tag
would
elimin
potenti
advers
effect
induc
fusion
protein
use
human
agreement
previou
report
result
studi
confirm
recombin
rbd
protein
without
fc
fusion
fragment
abl
induc
potent
neutral
antibodi
respons
protect
infect
sarscov
suggest
possibl
develop
rbd
subunitbas
vaccin
sar
prevent
